These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 19766043)

  • 1. [Atypical ductal and lobular hyperplasia of the breast].
    Bricou A; Delpech Y; Barranger E
    Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
    Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
    Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of high-risk breast lesions and ductal carcinoma in situ.
    Sewell CW
    Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.
    Allison KH; Eby PR; Kohr J; DeMartini WB; Lehman CD
    Hum Pathol; 2011 Jan; 42(1):41-50. PubMed ID: 20970167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do breast columnar cell lesions with atypia need to be excised?
    Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
    Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical lobular hyperplasia and lobular carcinoma in situ without other high-risk lesions diagnosed on vacuum-assisted core needle biopsy. The problem of excisional biopsy.
    Polom K; Murawa D; Pawelska A; Murawa P
    Tumori; 2009; 95(1):32-5. PubMed ID: 19366053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia.
    Grady I; Gorsuch H; Wilburn-Bailey S
    J Am Coll Surg; 2005 Jul; 201(1):14-7. PubMed ID: 15978438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology of the premalignant lesions of the breast.
    Saksela E
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():11-6. PubMed ID: 8298439
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgical therapy strategies in carcinoma in situ of the breast].
    Mosny DS
    Praxis (Bern 1994); 1998 Apr; 87(15):516-9. PubMed ID: 9608247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.